Reviewers from Health Canada using LORENZ docuBridge as their e-Review tool, as well as regulatory affairs professionals from industry presented their expert opinions and joined in constructive discussions as LORENZ provided interactive demonstrations of its docuBridge V, validator and review solutions.

"We are delighted to be able to co-host an event with RAPS and Regxia in Canada, which focuses on emerging trends in eSubmissions, while drawing upon LORENZ's partnership with Canadian and other global regulatory agencies," said Yaprak Eisinger, Managing Director, North America for LORENZ Life Sciences Group noting it was especially rewarding being able to bring together perspectives from Health Canada reviewers and members of industry to facilitate exchanging information and discussing future plans.
"My LORENZ colleagues and I have been working with Health Canada for over four years to help them make their E-REVIEW project a success with LORENZ docuBridge. This was a great opportunity to further spread the message that preparing electronic submissions using eCTD is a reasonable and realistic goal for all companies submitting to Health Canada," said Charles Mathis, Director QA for LORENZ Life Sciences Group.
Given the current need for understanding and leveraging the eCTD in Canada, and the overwhelming interest for attendance in the event, this seminar will be repeated in the fall of 2010 in Vancouver. Details will be posted shortly at www.lorenz.cc
About LORENZ Life Sciences Group
LORENZ Life Sciences Group (www.lorenz.cc) develops and markets software solutions for the Life Sciences market since 1989. LORENZ's solutions are geared specifically for submission assembly, review, publishing, validation and management. As the number one supplier of submission management systems in the world, as well as the largest supplier of eCTDs for U.S., European and Japanese submissions in the world, LORENZ is the technological market leader. With over 170 installations in 20 countries, LORENZ has built a reputable customer base. For more information, please click here to contact LORENZ. |